BioMarin Pharmaceutical Inc (BMRN): Price and Financial Metrics
BMRN Price/Volume Stats
| Current price | $58.23 | 52-week high | $94.85 |
| Prev. close | $58.10 | 52-week low | $52.93 |
| Day low | $57.70 | Volume | 1,517,303 |
| Day high | $58.98 | Avg. volume | 1,871,735 |
| 50-day MA | $57.69 | Dividend yield | N/A |
| 200-day MA | $64.22 | Market Cap | 11.17B |
BMRN Stock Price Chart Interactive Chart >
BioMarin Pharmaceutical Inc (BMRN) Company Bio
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU). (Source:Wikipedia)
BMRN Price Returns
| 1-mo | 3.58% |
| 3-mo | -2.98% |
| 6-mo | -5.44% |
| 1-year | -31.51% |
| 3-year | -33.13% |
| 5-year | -54.06% |
| YTD | -11.41% |
| 2024 | -31.83% |
| 2023 | -6.83% |
| 2022 | 17.14% |
| 2021 | 0.75% |
| 2020 | 3.71% |
Continue Researching BMRN
Here are a few links from around the web to help you further your research on Biomarin Pharmaceutical Inc's stock as an investment opportunity:Biomarin Pharmaceutical Inc (BMRN) Stock Price | Nasdaq
Biomarin Pharmaceutical Inc (BMRN) Stock Quote, History and News - Yahoo Finance
Biomarin Pharmaceutical Inc (BMRN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...